Marijuana Stocks

Much like the U.S. legal status on marijuana, the verdict on marijuana stocks is still up in the air. While the bulls like to think that the marijuana industry is about to explode with their optimism over the pending decriminalization and legalization of marijuana, the bears view marijuana stocks as a very risky investment to the point that they may be scams. Marijuana Penny Stocks such as Cannabis Science Inc (CBIS) are risky due to fact that they are in a grey legal area. But as Canada’s nascent legal marijuana market blossoms, many pot stocks are worth adding to your portfolio.

Related to Marijuana Stocks:

Constellation Brands’ Sad Fate Seems Written in the Stars

By Dana Blankenhorn, InvestorPlace Contributor
Constellation Brands and STZ stock once earned a premium for its CGC investment. Now it seems guaranteed to head lower.

The Bull Case for New Age Beverages Stock Still Isn’t Strong Enough

By David Moadel, InvestorPlace Contributor
Although New Age Beverages has an exciting product pipeline, it still isn't a good enough reason to to own NBEV stock right now.

Aurora Cannabis Is Approaching Baseball’s Mendoza Line

By Dana Blankenhorn, InvestorPlace Contributor
Aurora stock could hit the stock market's version of the Mendoza Line, the $1 mark, if companies can't take market share from street dealers.

It’s High Time Investors Buy Some Canopy Growth Shares

By Chris Tyler, InvestorPlace Contributor
After Canopy's solid earnings report, charts are indicating that it has hit a bottom. It's time for investors to pick up some CGC stock now.

3 Marijuana Stocks to Avoid at All Costs

By Marie Brodbeck, InvestorPlace Contributor
Marijuana stocks are looking like a good play for this year, but these three companies are not worth taking a risk on in 2020.

Canopy Growth’s Future Is Still Very Bright

By Chris Lau, InvestorPlace Contributor
Canopy Growth reported strong sales numbers and updated investors on its U.S. expansion. CGC stock still looks bright.

Even Under $2, Aurora Stock Remains Unattractive

By Faisal Humayun, InvestorPlace Contributor
Accelerated cash burn is a concern for Aurora stock, coupled with sluggish growth in medicinal and recreational cannabis. Further ACB equity dilution coming.

Recent Aurora Stock News Leaves Investors Wondering: Buy, Hold or Sell?

By Tezcan Gecgil, InvestorPlace Contributor
After the recent quarterly report and the general outlook, it is not prudent to recommend Aurora stock as a buy. Covered calls or put spreads present an alternative to play ACB.

30 Marijuana Stocks to Buy as the Future Turns Green

By Josh Enomoto, InvestorPlace Contributor
Thanks to favorable public sentiment and political tailwinds, the list of marijuana stocks to buy is both extensive and diverse.

Cannabis Stocks Are Flirting With a Bottom

By InvestorPlace Staff
Canopy Growth is leading the way toward a bottom in cannabis stocks after reporting better-than-expected revenue growth on Valentine's Day.

2020 Could Be the Year Cronos Comes Alive

By Will Ashworth, InvestorPlace Contributor
Cronos Group reports its fourth-quarter and full-year results on Feb. 27. Owners of CRON stock shouldn’t expect much in the near term.

30 Marijuana Stocks to Buy as the Future Turns Green

By Josh Enomoto, InvestorPlace Contributor
Thanks to favorable public sentiment and political tailwinds, the list of marijuana stocks to buy is both extensive and diverse.

Earnings Preview: Analysts Expect Canopy Growth’s Revenue to Slump

By Mark R. Hake, CFA
CGC stock is likely to languish after its fiscal third-quarter earnings report unless it can prove it's on track to be profitable soon.

OrganiGram Stock is a Reasonable Cannabis Bet Amid a Sea of Riskier Ones

By Josh Enomoto, InvestorPlace Contributor
OrganiGram stock skyrocketed off its fiscal Q1 earnings report but just as quickly came tumbling back down. However, the underlying company is better positioned than most to enjoy a solid year in 2020.

Canopy Growth Stock Remains a Long-Term Buy Ahead of Earnings

By InvestorPlace Research Staff
CGC stock has faded again into earnings, and cannabis stocks could see volatility ahead. But any dip is a long-term buying opportunity.

Canopy Growth Needs to Keep Cash High in Order to Survive

By Dana Blankenhorn, InvestorPlace Contributor
New CEO David Klein needs to limit his cash burn and save struggling Cannabis 2.0 investments in order for CGC stock to survive.

2020 Now Looks Even Uglier for Aurora Cannabis Stock

By Chris Tyler, InvestorPlace Contributor
Aurora stock needs to show investors the money soon. And this week's earnings report isn't likely to bring much money, or hope.

Stick with the Recent Rally in Canopy Growth Stock

By Luke Lango, InvestorPlace Senior Investment Analyst
After plunging in 2019, CGC stock could rebound in a big way in 2020 thanks to three major growth catalysts.

Aurora Cannabis Stock Is Losing Cash and Liquidity Options

By Mark R. Hake, CFA
Aurora Cannabis is running out of cash and liquidity options-- and will likely have to raise equity that will further dilute Aurora stock.
Load More